Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A

Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A

SSZSE:301290
24.50
CNY
-0.52
(-2.08%)
0.74EPS
38.03P/E
2.87BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A carries a market capitalization of 2.87B, placing it among publicly traded companies globally. Its enterprise value stands at 2.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.87B
Enterprise Value2.30B

Share Statistics

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A has 100.17M shares outstanding.

Shares Outstanding100.17M

Valuation Ratios

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 38.03. The price-to-sales ratio is 6.53, and the price-to-book ratio stands at 1.33.

PE Ratio38.03
PS Ratio6.53
PB Ratio1.33
P/TBV Ratio2.55

Enterprise Valuation

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A trades at an EV/EBITDA multiple of 26.49 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.49 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.30B versus a market cap of 2.87B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales5.31
EV / EBITDA26.49
EV / EBIT26.49

Financial Position

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A maintains a current ratio of 3.03, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.75, indicating elevated leverage, while an interest coverage ratio of 32.09 demonstrates strong ability to service its debt obligations.

Current Ratio3.03
Quick Ratio2.04
Debt / Equity19.75
Debt / EBITDA4.99
Interest Coverage32.09

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A posted a return on equity (ROE) of 3.40, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.96 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.70, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.16, useful for judging operating efficiency across full business cycles. The company generates approximately 596,348.53 in revenue per employee across its workforce of 727.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.91 indicates how many times Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)3.40
Return on Assets (ROA)2.70
Return on Invested Capital (ROIC)2.96
Return on Capital Employed (ROCE)3.16
Revenue Per Employee596,348.53
Employee Count727.00
Inventory Turnover0.91

Taxes

CNY

Over the twelve months ended September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A recorded 13.25M in income tax expense. That works out to an effective tax rate of 15.37, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 86.18M, leaving 74.47M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax13.25M
Effective Tax Rate15.37

Stock Price Statistics

CNY

As of the close on November 17, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A's stock has declined approximately 10.55% over the past 52 weeks. The 50-day moving average sits at 26.70, while the 200-day moving average is 28.07.

52-Week Price Change-10.55%
50-Day Moving Average26.70
200-Day Moving Average28.07

Income Statement

CNY

Over the twelve months ended September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A generated 433.55M in revenue and converted that into 74.47M in net income, yielding earnings per share of 0.74. EBITDA reached 86.98M, while operating income came in at 62.61M.

Revenue433.55M
Gross Profit222.37M
Operating Income62.61M
Pretax Income86.18M
Net Income74.47M
EBITDA86.98M
EBIT86.98M
Earnings Per Share (EPS)0.74

Balance Sheet

CNY

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A holds 1.04B in cash and equivalents against 433.90M in total debt, resulting in a net debt position of 341.57M. Total book value stands at 2.16B, with working capital of 1.04B providing operational flexibility.

Cash & Cash Equivalents1.04B
Total Debt433.90M
Net Debt341.57M
Equity (Book Value)2.16B
Book Value Per Share21.53
Working Capital1.04B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-58.56M

Margins

Over the twelve months ended September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A posted a gross margin of 51.29, reflecting its pricing power and cost economics. The operating margin of 14.44 and net profit margin of 17.18 provide insight into operational efficiency.

Gross Margin51.29
Operating Margin14.44
Pretax Margin19.88
Profit Margin17.18
EBITDA Margin20.06

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A paid dividends of 0.33 per share. The dividend payout ratio of 45.16 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -9.80, meaning Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Dividend Per Share0.33
Payout Ratio45.16
Shareholder Yield-9.80

Scores

As of September 30, 2026, Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A has an Altman Z-Score of 3.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.23